Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer
2008 · Journal of drug targeting · 48 citations
https://doi.org/10.1080/10611860802229978
N
Ning Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
1.7K
Citations
23
h-index
33
i10-index
Ning Yu is an academic researcher from Qingdao University. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Acute Myeloid Leukemia Research & Intracerebral and Subarachnoid Hemorrhage Research. The author has an h-index of 23, co-authored 80 publications.
ORCID: 0000-0003-2812-9300Papers by this author
worksA new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action
2020 · Molecular Immunology · 47 citations
https://doi.org/10.1016/j.molimm.2020.01.009
Targeting of CD34+CD38-cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
2012 · BMC Cancer · 12 citations
https://doi.org/10.1186/1471-2407-12-431
Cellular uptake of a cationic amphiphilic fluorophore in the form of assemblies via Clathrin-dependent endocytosis
2021 · Materials & Design · 7 citations
https://doi.org/10.1016/j.matdes.2021.109464
Effect of opioids on constipation in critically ill patients: A meta-analysis
2023 · Australian Critical Care · 7 citations
https://doi.org/10.1016/j.aucc.2023.06.006
NDP52 deficiency accelerates chondrocyte degeneration through promoting pathogenic mitochondrial ROS via reverse electron transport
2025 · Redox Biology · 2 citations
https://doi.org/10.1016/j.redox.2025.103747
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat